13,576 Shares in Xylem Inc. $XYL Acquired by Nuance Investments LLC

Nuance Investments LLC bought a new position in Xylem Inc. (NYSE:XYLFree Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 13,576 shares of the industrial products company’s stock, valued at approximately $1,605,000.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. AQR Capital Management LLC grew its holdings in shares of Xylem by 14.4% during the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after acquiring an additional 3,900 shares in the last quarter. NewEdge Advisors LLC boosted its stake in shares of Xylem by 3.3% during the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock worth $496,000 after acquiring an additional 132 shares in the last quarter. Empowered Funds LLC grew its holdings in Xylem by 56.1% during the first quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after purchasing an additional 3,120 shares during the last quarter. Arrowstreet Capital Limited Partnership grew its stake in Xylem by 97.6% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,151 shares of the industrial products company’s stock valued at $1,442,000 after buying an additional 5,509 shares during the last quarter. Finally, EverSource Wealth Advisors LLC increased its stake in shares of Xylem by 114.0% in the second quarter. EverSource Wealth Advisors LLC now owns 1,192 shares of the industrial products company’s stock worth $154,000 after purchasing an additional 635 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Price Performance

Shares of XYL opened at $117.59 on Tuesday. The stock has a market cap of $27.46 billion, a P/E ratio of 28.00, a price-to-earnings-growth ratio of 1.66 and a beta of 1.02. The stock’s 50-day moving average price is $117.63 and its two-hundred day moving average price is $120.33. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23. Xylem Inc. has a 1 year low of $105.29 and a 1 year high of $154.27.

Xylem (NYSE:XYLGet Free Report) last issued its earnings results on Tuesday, July 28th. The industrial products company reported $1.46 EPS for the quarter, beating the consensus estimate of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The firm had revenue of $2.34 billion during the quarter, compared to the consensus estimate of $2.34 billion. During the same quarter in the prior year, the firm earned $1.26 earnings per share. The business’s quarterly revenue was up 1.5% on a year-over-year basis. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, equities analysts predict that Xylem Inc. will post 5.67 earnings per share for the current year.

Xylem Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Thursday, August 27th will be given a $0.43 dividend. The ex-dividend date is Thursday, August 27th. This represents a $1.72 annualized dividend and a dividend yield of 1.5%. Xylem’s payout ratio is currently 40.95%.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on XYL shares. CLSA raised shares of Xylem to a “hold” rating in a research report on Thursday, June 25th. Mizuho increased their target price on Xylem from $124.00 to $130.00 and gave the stock a “neutral” rating in a report on Wednesday, July 29th. Weiss Ratings reissued a “hold (c)” rating on shares of Xylem in a report on Wednesday, August 5th. Royal Bank Of Canada lifted their price objective on Xylem from $159.00 to $164.00 and gave the company an “outperform” rating in a research report on Wednesday, July 29th. Finally, Barclays boosted their target price on shares of Xylem from $154.00 to $159.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 29th. Nine equities research analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $154.23.

Check Out Our Latest Research Report on Xylem

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.